Pharma industry questions FDA on platform technology designation program
Regulatory NewsJoanne S. Eglovitch
Advanced therapies/cell and gene therapyBiologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)PharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyUnited States